Cytochrome P-450 CYP2D6 Inhibitors
"Cytochrome P-450 CYP2D6 Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6.
| Descriptor ID |
D065690
|
| MeSH Number(s) |
D27.505.389.500.368 D27.505.519.389.335.368
|
| Concept/Terms |
Cytochrome P-450 CYP2D6 Inhibitors- Cytochrome P-450 CYP2D6 Inhibitors
- Cytochrome P 450 CYP2D6 Inhibitors
- P450 CYP2D6 Inhibitors
- CYP2D6 Inhibitors, P450
- Inhibitors, P450 CYP2D6
- CYP2D6 Inhibitors
- Inhibitors, CYP2D6
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP2D6 Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP2D6 Inhibitors".
This graph shows the total number of publications written about "Cytochrome P-450 CYP2D6 Inhibitors" by people in this website by year, and whether "Cytochrome P-450 CYP2D6 Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2011 | 1 | 2 | 3 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytochrome P-450 CYP2D6 Inhibitors" by people in Profiles.
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy. Clin Pharmacol Ther. 2018 05; 103(5):770-777.
-
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials. Clin Cancer Res. 2011 Nov 01; 17(21):6944-51.
-
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine. Semin Oncol. 2011 Apr; 38(2):263-73.
-
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen? Expert Rev Anticancer Ther. 2011 Feb; 11(2):185-93.
-
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004 Oct 26; 63(8):1364-70.